DERM

Journey Medical Corp

5.17

Oct 30 • 3:59 PM ET -0.24 (-4.44%)

5.20

Aftermarket • 7:30 PM ET +0.03 (0.58%)

Healthcare Drug Manufacturers - Specialty & Generic USA Micro NASD

Peers: BHC BFRI VRCA EOLS ARQT HROW ORGO SLGL CPIX DRMA

| Held by: VTI VXF IWC QQQS DFMC DCOR

Scroll to Statements

Index	-
Market Cap	145.92M
Enterprise Value	145.82M
Income	-6.10M
Sales	68.18M
Book/sh	1.16
Cash/sh	0.91
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	58
IPO	Nov 12, 2021

P/E	-
Forward P/E	11.68
PEG	-
P/S	2.14
P/B	4.45
P/C	5.69
P/FCF	-
EV/EBITDA	111.31
EV/Sales	2.14
Quick Ratio	1.41
Current Ratio	1.59
Debt/Eq	0.80
LT Debt/Eq	0.64
Option/Short	Yes / Yes

EPS (ttm)	-0.23
EPS next Y	0.44
EPS next Q	-0.02
EPS this Y	73.40%
EPS next Y	454.00%
EPS next 5Y	-
EPS past 3/5Y	34.88% -
Sales past 3/5Y	-5.66% 6.79%
EPS Y/Y TTM	40.71%
Sales Y/Y TTM	20.89%
EPS Q/Q	93.01%
Sales Q/Q	23.33%
Earnings	Aug 12 AMC
EPS/Sales Surpr.	55.56% 0.82%

Insider Own	48.50%
Insider Trans	0.00%
Inst Own	36.20%
Inst Trans	-12.46%
ROA	-6.80%
ROE	-23.77%
ROIC	-11.61%
Gross Margin	59.26%
Oper. Margin	-4.41%
Profit Margin	-8.95%
SMA20	-5.09%
SMA50	-20.69%
SMA200	-22.16%
Trades

Shs Outstand	21.66M
Shs Float	14.53M
Short Float	20.56%
Short Ratio	15.29
Short Interest	2.99M
52W High	9.56 -45.89%
52W Low	4.31 19.95%
Volatility	4.99% 6.35%
ATR (14)	0.34
RSI (14)	40.47
Beta	1.11
Rel Volume	1.20
Avg Volume	195.38K
Volume	235,062

Perf Week	2.99%
Perf Month	-23.07%
Perf Quarter	-20.09%
Perf Half Y	-0.39%
Perf YTD	-32.94%
Perf Year	-37.79%
Perf 3Y	61.56%
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	13.75
Prev Close	5.41
Price	5.17
Change %	-4.44%

Consensus

Strong Buy

Avg. Price Target

$13.75

Implied Upside

+166.0%

Analysts4incl. previous ratings

Rating Distribution4 Buy · 0 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Aug 25, 2025	Initiated	HH.C. Wainwright	Buy	$13	+151.5%
Jul 30, 2025	Resumed	RB. Riley Securities	Buy	$12	+132.1%
Aug 22, 2024	Initiated	RRodman & Renshaw	Buy	$9	+74.1%
Jun 28, 2024	Resumed	RROTH MKM	Buy	$11	+112.8%
Dec 07, 2021	Initiated	RB. Riley Securities	Buy	$14	+170.8%

Sep-08-26 04:05PM	Journey Medical Corporation to Participate in September 2026 Investor Conferences (GlobeNewswire) -6.52%
Aug-13-26 01:02AM	Journey Medical Corp (DERM) (Q2 2026) Earnings Call Highlights: Emrosi Surges 20% Sequentially, ... (GuruFocus.com)
Aug-12-26 04:01PM	Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Aug-11-26 09:23AM	Earnings To Watch: Journey Medical Corp (DERM) Q2 2026 -- GF Value Sees 6% Upside (GuruFocus.com)
Aug-05-26 08:30AM	Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026 (GlobeNewswire)
04:45PM	Loading…
May-19-26 04:45PM	Journey Medical Corporation to Participate in A.G.P.'s Annual Virtual Healthcare Conference (GlobeNewswire)
May-14-26 01:01AM	Journey Medical Corp (DERM) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ... (GuruFocus.com) +22.35%
May-13-26 04:01PM	Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights (GlobeNewswire)
May-06-26 04:01PM	Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026 (GlobeNewswire)
Apr-21-26 08:30AM	Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi (GlobeNewswire) -5.20%
Mar-25-26 11:01PM	Journey Medical Corp (DERM) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com) -30.01%
04:01PM	Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Mar-24-26 09:16AM	Journey Medical Corp (DERM) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Mar-18-26 08:30AM	Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026 (GlobeNewswire) -5.07%
Jan-08-26 02:00PM	Journey Medical (DERM) Publishes Positive Emrosi Phase 1 Microbiome Data (Insider Monkey)
08:30AM	Loading…
Dec-10-25 08:30AM	Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology (GlobeNewswire) -5.29%
Nov-19-25 08:18AM	What Makes Journey Medical Corporation (DERM) a Good Investment? (Insider Monkey)
Nov-17-25 08:06PM	Journey Medical Corp (DERM) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Nov-12-25 06:30PM	Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key Metrics (Zacks) -15.31%
05:15PM	Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:01PM	Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Nov-11-25 07:31AM	What To Expect From Journey Medical Corp (DERM) Q3 2025 Earnings (GuruFocus.com)
Nov-10-25 05:20PM	Guardian Pharmacy Services (GRDN) Q3 Earnings and Revenues Surpass Estimates (Zacks)
Nov-05-25 06:35PM	electroCore, Inc. (ECOR) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
08:30AM	Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025 (GlobeNewswire)
Nov-04-25 06:35PM	OmniAb, Inc. (OABI) Reports Q3 Loss, Misses Revenue Estimates (Zacks) +5.63%
Oct-24-25 08:30AM	Journey Medical Corporation Reports Combined Emrosi (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference (GlobeNewswire)
Oct-08-25 08:30AM	Journey Medical Corporation to Participate in October 2025 Investor Conferences (GlobeNewswire)
Sep-22-25 09:03AM	Summers Value Partners' Update on Journey Medical (DERM) (Insider Monkey)
Sep-04-25 08:06AM	New Strong Sell Stocks for September 4th (Zacks)
08:30AM	Loading…
Sep-03-25 08:30AM	Journey Medical Corporation to Participate in September 2025 Investor Conferences (GlobeNewswire)
Aug-18-25 08:30AM	Journey Medical Corporation to Present at the Emerging Growth Conference (GlobeNewswire)
Aug-13-25 07:00PM	Journey Medical Corp (DERM) Q2 2025 Earnings Call Highlights: Strong Arosi Launch Drives ... (GuruFocus.com) -15.11%
Aug-12-25 05:15PM	Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates (Zacks) +8.51%
04:01PM	Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Aug-11-25 09:36AM	Journey Medical Corp (DERM) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
09:10AM	3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates (Zacks)
Aug-07-25 08:30AM	Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11 (GlobeNewswire)
Aug-05-25 04:01PM	Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025 (GlobeNewswire)
Aug-04-25 10:00AM	Journey Medical Corporation (DERM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
Jul-14-25 08:30AM	Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi (GlobeNewswire)
Jun-24-25 08:30AM	Journey Medical to Join Russell 2000 and Russell 3000 Indexes (GlobeNewswire) +8.93%
Jun-21-25 08:35AM	Journey Medical announces data analysis from Phase 3 trials of Emrosi (TipRanks)
Jun-20-25 08:30AM	Journey Medical Corporation Announces Emrosi Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference (GlobeNewswire)
Jun-09-25 08:30AM	Journey Medical Corporation Announces Emrosi Featured on "The Balancing Act" Airing on Lifetime TV (GlobeNewswire)
May-15-25 07:01PM	Journey Medical Corp (DERM) Q1 2025 Earnings Call Highlights: Amrosi Launch Boosts Margins ... (GuruFocus.com) +18.93%
04:05PM	Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights (GlobeNewswire)
May-14-25 05:10PM	Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -5.54%
04:01PM	Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights (GlobeNewswire)
May-13-25 09:41AM	What To Expect From Journey Medical Corp (DERM) Q1 2025 Earnings (GuruFocus.com) -7.47%
May-12-25 07:10AM	Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
May-08-25 06:15PM	The Joint Corp. (JYNT) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-07-25 04:01PM	Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025 (GlobeNewswire) +6.92%
May-06-25 05:20PM	Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Lags Revenue Estimates (Zacks) -5.39%
May-05-25 09:57AM	Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength? (Zacks)
Apr-30-25 05:25AM	Why Journey Medical Corporation (DERM) is Surging in 2025 (Insider Monkey)
Apr-23-25 07:00AM	Journey Medical (DERM) Moves 16.8% Higher: Will This Strength Last? (Zacks)
Apr-18-25 05:46PM	Is Journey Medical Corporation (DERM) a Cheap Hot Stock to Buy Right Now? (Insider Monkey)
Apr-07-25 09:17AM	Journey Medical (DERM) Surges 9.1%: Is This an Indication of Further Gains? (Zacks)
Apr-01-25 04:01PM	Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer (GlobeNewswire)
Mar-31-25 04:05PM	Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Mar-27-25 08:25AM	Q4 2024 Journey Medical Corp Earnings Call (Thomson Reuters StreetEvents)
03:02AM	Journey Medical Corp (DERM) Q4 2024 Earnings Call Highlights: Strategic Launch of Emrosi and ... (GuruFocus.com)
Mar-26-25 07:10PM	Journey Medical Corporation (DERM) Q4 2024 Earnings Call Transcript (SeekingAlpha) -5.25%
05:15PM	Journey Medical Corporation (DERM) Tops Q4 Earnings Estimates (Zacks)
04:01PM	Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Mar-25-25 09:04AM	Journey Medical Corp (DERM) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
08:50AM	Journey Medical launches Emrosi for the treatment of rosacea (TipRanks)
Mar-24-25 08:30AM	Journey Medical Corporation Launches Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea (GlobeNewswire) +13.94%
Mar-19-25 04:01PM	Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025 (GlobeNewswire) +7.88%
Mar-12-25 08:30AM	Journey Medical Corporation to Participate in the 37th Annual ROTH Conference (GlobeNewswire)
Mar-05-25 04:01PM	Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi (DFD-29) to Treat Rosacea (GlobeNewswire)
Mar-04-25 04:01PM	Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida (GlobeNewswire)
Feb-20-25 02:38PM	Journey Medical Corporation (DERM): A Bull Case Theory (Insider Monkey)
Jan-24-25 08:57AM	Minot Light Capitals Largest Performance Detractor in Q4: Journey Medical (DERM) (Insider Monkey) +8.05%
Jan-23-25 08:30AM	Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea (GlobeNewswire)
Nov-14-24 04:10PM	Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Nov-12-24 05:25PM	Journey Medical Corporation (DERM) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -6.06%
04:01PM	Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Nov-05-24 11:29AM	FDA approves Journey Medicals rosacea treatment Emrosi (Pharmaceutical Technology)
Nov-04-24 07:18AM	Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock? (Zacks) -13.78%
07:00AM	Journey Medical Corporation Announces U.S. FDA Approval of Emrosi (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea (GlobeNewswire)
Oct-25-24 08:30AM	Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference (GlobeNewswire) +6.27%
Oct-17-24 04:15PM	SWK Holdings Provides Portfolio Update (ACCESSWIRE)
Oct-03-24 08:30AM	Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference (GlobeNewswire)
Sep-09-24 08:30AM	Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference (GlobeNewswire)
Sep-04-24 08:15AM	Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Aug-13-24 04:05PM	Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire) +14.22%
Aug-12-24 05:10PM	Journey Medical Corporation (DERM) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -15.26%
04:01PM	Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Aug-06-24 04:01PM	Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024 (GlobeNewswire)
Jul-17-24 04:15PM	SWK Holdings Highlights Recent Achievements and Provides Portfolio Update (ACCESSWIRE)
Jul-11-24 04:05PM	Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors (GlobeNewswire)
May-15-24 04:15PM	Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire)
04:01PM	Journey Medical Corporation to Participate in the Alliance Global Partners' (A.G.P.) Virtual Healthcare Company Showcase (GlobeNewswire)
May-14-24 03:07AM	Journey Medical Corp (DERM) (Q1 2024) Earnings Call Transcript Highlights: Navigating Growth ... (GuruFocus.com)
May-13-24 08:55PM	DERM Stock Earnings: Journey Medical Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)

Show Previous News

Journey Medical Corporation is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.

Executive ChairmanDr. Lindsay Allan Rosenwald M.D.

FounderMr. Claude Maraoui

CFO & Corporate ControllerMr. Joseph M. Benesch

COOMr. Ramsey Alloush

Executive Director of MarketingMr. Brian Prout

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DERM

Journey Medical Corp

Upgrade your Finviz experience